Shopping Cart
Remove All
Your shopping cart is currently empty
Lupartumab (BAY 1112623) is a monoclonal antibody targeting LYPD3 (C4.4A) and is employed in the synthesis of antibody-active molecular couplers for studying LYPD3-associated tumor diseases.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $297 | - | In Stock | |
| 5 mg | $778 | - | In Stock | |
| 10 mg | $1,230 | - | In Stock | |
| 25 mg | $1,850 | - | In Stock | |
| 50 mg | $2,490 | - | In Stock | |
| 100 mg | $3,360 | - | In Stock |
| Description | Lupartumab (BAY 1112623) is a monoclonal antibody targeting LYPD3 (C4.4A) and is employed in the synthesis of antibody-active molecular couplers for studying LYPD3-associated tumor diseases. |
| Synonyms | BAY 1112623 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Molecular Weight | 150 kDa |
| Cas No. | 1640971-88-5 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.